BiotechTube
Home/Vaxxas/Scott Fry, Ph.D.
SF

Scott Fry, Ph.D.

Chief Operating Officer

Vaxxas

Therapeutic Areas

Infectious DiseaseOncology

Vaxxas Pipeline

DrugIndicationPhase
HD-MAP Influenza VaccineInfluenza PreventionPhase 2/3
Platform Partnerships (e.g., with Merck)Various Infectious DiseasesPre-clinical/Phase 1

Leadership Team at Vaxxas

DP
David Peacock
Chief Executive Officer
AF
Angus Forster, Ph.D.
Chief Technology Officer
TL
Tom Lake
Chief Business Officer
SM
Sarah Meibusch
Board Chair
View full Vaxxas profile